TABLE I. Provisional cases of selected* infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), United States,
week ending January 10, 2015 (WEEK 01)†

Disease Total cases reported for previous years
Current
week		 Cum
2015		 5-year
weekly
average§		 2014 2013 2012 2011 2010 States reporting cases
during current week (Count)
 Anthrax - - - - - - 1 -  
 Arboviral diseases **,††:                  
 California serogroup virus disease - - 0 80 95 81 137 75  
 Chikungunya virus disease ¶ NN NN 0 NN NN NN NN NN  
 Eastern equine encephalitis virus disease - - 0 8 8 15 4 10  
 Powassan virus disease - - - 8 12 7 16 8  
 St. Louis encephalitis virus disease - - 0 9 1 3 6 10  
 Western equine encephalitis virus disease - - - - - - - -  
 Botulism, total - - 3 141 152 168 153 112  
 foodborne - - 0 11 4 27 24 7  
 infant - - 2 111 136 123 97 80  
 other(wound & unspecified) - - 0 19 12 18 32 25  
 Brucellosis - - 2 85 99 114 79 115  
 Chancroid - - 0 17 - 15 8 24  
 Cholera - - 1 - 14 17 40 13  
 Cyclosporiasis †† - - 2 369 784 123 151 179  
 Diphtheria - - - 1 - 1 - -  
 Haemophilus influenzae,
invasive disease (age <5 yrs) §§:		                  
 serotype b - - 1 29 31 30 14 23  
 nonserotype b - - 4 174 222 205 145 200  
 unknown serotype 3 3 5 227 185 210 226 223 NYC (1 ), PA (1 ), OH (1 )
 Hansen disease †† - - 2 52 81 82 82 98  
 Hantavirus Infections ††:                  
 Hantavirus infection (non-HPS) ¶ NN NN - NN NN NN NN NN  
 Hantavirus pulmonary syndrome (HPS) - - 0 25 21 30 23 20  
 Hemolytic uremic syndrome, post-diarrheal †† 1 1 4 219 329 274 290 266 NYC (1 )
 Hepatitis B, virus infection perinatal - - 1 35 48 40 NP NP  
 Influenza-associated pediatric mortality ††,¶¶ 19 19 4 130 160 52 118 61 OH (2 ), WI (1 ), MN (1 ), IA (2 ), SC (1 ), KY (3 ), TN (1 ), LA (2 ), OK (2 ), CO (1 ), KS (1 ), TX (1 ), VA (1 )
 Leptospirosis †† - - 0 21 NN NN NN NN  
 Listeriosis 5 5 13 661 735 727 870 821 NYC (1 ), OH (1 ), MD (2 ), OR (1 )
 Measles *** 1 1 2 628 187 55 220 63 SD (1 )
 Meningococcal disease, invasive †††:                  
 serogroup ACWY - - 5 98 142 161 257 280  
 serogroup B - - 2 63 99 110 159 135  
 other serogroup - - 1 19 17 20 20 12  
 unknown serogroup 3 3 9 222 298 260 323 406 VA (1 ), FL (2 )
 Novel influenza A infection virus §§§ - - 11 3 21 313 14 4  
 Plague - - - 5 4 4 3 2  
 Poliomyelitis, paralytic - - - - 1 - - -  
 Polio virus infection, nonparalytic †† - - - - - - - -  
 Psittacosis †† - - 0 7 6 2 2 4  
 Q fever total ††: - - 3 137 170 135 134 131  
 acute - - 2 111 137 113 110 106  
 chronic - - 1 26 33 22 24 25  
 Rabies, human - - 0 1 2 1 6 2  
 SARS CoV †† - - - - - - - -  
 Smallpox †† - - - - - - - -  
 Streptococcal toxic-shock syndrome †† 3 3 5 194 224 194 168 142 ME (1 ), OH (1 ), NE (1 )
 Syphilis, congenital (age <1 yr) ††,¶¶¶ - - 6 306 348 322 360 377  
 Toxic-shock syndrome (staphylococcal) †† - - 2 49 71 65 78 82  
 Trichinellosis †† - - 0 15 22 18 15 7  
 Tularemia - - 1 150 203 149 166 124  
 Typhoid fever - - 8 293 338 354 390 467  
 Vancomycin-intermediate Staphylococcus aureus †† - - 3 193 248 134 82 91  
 Vancomycin-resistant Staphylococcus aureus †† - - 0 - - 2 - 2  
 Viral hemorrhagic Fevers ††,****:                  
 Crimean-Congo hemorrhagic fever - - - NP NP NP NP NP  
 Ebola hemorrhagic fever - - - 6 NP NP NP NP  
 Guanarito hemorrhagic fever - - - NP NP NP NP NP  
 Junin hemorrhagic fever - - - NP NP NP NP NP  
 Lassa fever - - - 1 NP NP NP NP  
 Lujo virus - - - NP NP NP NP NP  
 Machupo hemorrhagic fever - - - NP NP NP NP NP  
 Marburg fever - - - NP NP NP NP NP  
 Sabia-associated hemorrhagic fever - - - NP NP NP NP NP  
 Yellow fever - - - - - - - -  
[ Export This Table ]  [ Next Table ]  [ Weekly Tables ]  [ Annual Tables ]

-: No reported cases    N: Not reportable.    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.
* Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions.
† Case counts for reporting years 2014 and 2015 are provisional and subject to change. For further information on interpretation of these data, see
http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.
§ Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. The total sum of incident cases is then divided by 25 weeks. Additional information is available at http://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf.
¶ Data for the Arboviral disease, Chikungunya, and Hantavirus infection disease, non-Hantavirus Pulmonary Syndrome (HPS), will be displayed in this table after the CDC obtains Office of Management and Budget Paperwork Reduction Act approval to receive data for these conditions.
** Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
†† Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the Arboviral diseases, STD data, TB data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.
§§ Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II.
¶¶ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Please refer to the MMWR publication for weekly updates to the footnote for this condition.
*** Please refer to the MMWR publication for weekly updates to the footnote for this condition.
††† Data for meningococcal disease (all serogroups) are available in Table II.
§§§ Please refer to the MMWR publication for weekly updates to the footnote for this condition.
¶¶¶ Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
**** Please refer to the MMWR publication for weekly updates to the footnote for this condition. See Table II for Dengue Hemorrhagic Fever.

National Notifiable Diseases Surveillance System (NNDSS)

MMWR web application provided by CDC WONDER,  http://wonder.cdc.gov
Content source: CDC WONDER